Recent Updates
Recently added Catalysts
ORIC Positive Sentiment

ORIC Pharmaceuticals to Present at the Leerink Partners Global Biopharma Conference

Wednesday, March 6, 2024 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: ORIC Pharmaceuticals, Inc. has announced it will present at the Leerink Partners Global Biopharma Conference on March 13, 2024. The presentation will cover a company overview and their focus on developing therapies that combat mechanisms of therapeutic resistance in oncology. Investors can access the live webcast through the company's website, with a replay available for 90 days post-event.
Price reaction · baseline $15.49 (2024-03-05 close) · hit after-hours · 1 other ORIC headline(s) in the window, move may be shared
day 0 close · peak
+3.5%

Market Sentiment Analysis

POSITIVE FACTORS

  • ORIC Pharmaceuticals is set to present at a notable biopharma conference.
  • The presentation aims to provide insights into their innovative oncology treatments.
  • The company is focused on addressing therapeutic resistance, which is a critical area in oncology.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+58%
120-day peak, hindsight
Typical move
10.1%
average across 6 past catalysts
Cash runway
~36 mo
Minimal dilution risk
Lead asset
ORIC-944
Phase 1 · Metastatic Prostate Cancer

Full Press Release Details

SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, March 06, 2024 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance, today announced that management will present a company overview at the Leerink Partners Global Biopharma Conference on Wednesday, March 13, 2024, at 8:00 a.m. ET.
A live webcast of the presentation will be available through the investor section of the company’s website at www.oricpharma.com. A replay of the webcast will be available for 90 days following the event.
About ORIC Pharmaceuticals, Inc.

Frequently Asked Questions

When will ORIC Pharmaceuticals present at the Leerink Partners Conference?

ORIC Pharmaceuticals will present on March 13, 2024, at 8:00 a.m. ET.

How can I watch the ORIC Pharmaceuticals presentation?

The presentation will be streamed live on the investor section of their website.

Is there a replay available for the presentation?

Yes, a replay of the webcast will be accessible for 90 days after the event.

Who is the CFO of ORIC Pharmaceuticals?

Dominic Piscitelli is the Chief Financial Officer of ORIC Pharmaceuticals.

ShareAdd on Google
Tags: ORIC Viatris Investor Conferences Healthcare ORIC Pharmaceuticals biopharma conference oncology therapeutic resistance Nasdaq: ORIC
Last updated: Mar 6, 2024

Biotech snapshot

Cash runway
$388M liquidity · $11M/mo burn
~36 mo
Minimal dilution risk
Lead asset
ORIC-944Phase 1
Metastatic Prostate Cancer →

Catalyst track record

+58%
best trade around ORIC's most recent catalyst

Peak hindsight return over a 120-day window, across 6 tracked FDA/PDUFA catalysts for ORIC.

See every catalyst's timing & PoA →